瘤病毒:一种有前途的疗法,用于恶性肺溢液和固体瘤
Xinya Wang1, Qin Zhou1, Xuyan Zhang1
1National "111" Center for Cellular Regulation and Molecular Pharmaceutics, Key Laboratory of Fermentation Engineering (Ministry of Education), Cooperative Innovation Center of Industrial Fermentation (Ministry of Education & Hubei Province), School of Life and Health Sciences, Hubei University of Technology, Wuhan, China.
Frontiers in immunology
|May 12, 2025
概括
瘤病毒 (OV) 直接摧毁瘤细胞,并提高抗瘤免疫力. 本综述探讨了对恶性多叶流血 (MPE) 和固体瘤的OV治疗,包括挑战和监管方面.
科学领域:
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
背景情况:
- 瘤病毒 (OV) 是一种选择性地感染和溶解癌细胞的病毒.
- OVs可以通过释放瘤抗原和激活炎症途径来刺激抗瘤免疫反应.
- 这种双重机制为各种癌症提供了有前途的治疗策略,包括恶性肺溢液 (MPE).
研究的目的:
- 审查瘤溶解性病毒治疗的进展,特别是恶性多流液 (MPE) 的进展.
- 突出表达OVs的内和内注射途径的潜力.
- 讨论OV治疗的挑战,安全性和监管格局.
主要方法:
- 关于型病毒研究的文献综述.
- 对专注于内和内输卵管输送的研究进行分析.
- 讨论瘤微环境 (TME) 及其对OV疗效的影响.
主要成果:
- OVs表现出直接瘤溶解和免疫启动能力.
- 胸腔内输送显示了MPE的潜力,但面临着复杂的胸腔环境带来的挑战.
- 内传递也在探索中,有效性因瘤类型和OV特征而有所不同.
结论:
- 瘤溶解病毒疗法为MPE和固体瘤提供了一种新的方法.
- 克服内环境中的挑战,解决安全和监管方面的问题对于临床翻译至关重要.
- 需要进一步的研究来优化OV输送和疗效.
相关概念视频
Tumor Immunotherapy
406
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
406
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
Cancer Vaccines
260
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
260
Pleural Effusion II: Symptoms and Management
135
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
135
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Rous Sarcoma Virus (RSV) and Cancer
4.9K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
4.9K


